Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$8.21
-1.78%today
MKT CAP
$159M
+15.6% · 1Y
Earnings History
-733.3%
Q4 '25
Analyst Targets
Current price
$8.21
Low
$20.00
Analyst Mean
$27.67
High
$40.00
3 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-2.1x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership1.7%
Institutional Ownership6.2%
Short % of Float-
Days to Cover0.7d
1 Week+6.5%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | fund | 0.47% | $0.00B | +0.00% | 2025-10-31 |
| China Universal Asset Management Co., Ltd. | institution | 0.03% | $0.00B | +100.00% | 2026-03-31 |
| UBS Group AG | institution | 0.00% | $0.00B | +100.00% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for MSLE.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.